Shots: Glenmark has launched Remogliflozin (SGLT2 inhibitors, 100mg, ) + Vildagliptin (DPP4 inhibitors, 50mg,) + Metformin (500/1000mg) as FDC for the management of T2D in India. The FDC will be […]readmore
Tags : vildagliptin
Shots: Eris Lifesciences acquired Novartis’ novel therapy Zomelis for $13M (~INR 93 crore) and will initiate the commercialization of product from Dec 10, 2019 in India The acquisition of Zomelis […]readmore
Shots: The P-IV VERIFY study involves assessing of Galvus (50mg, bid) + Metformin (1000–2000 mg, qd) vs SOC monothx. approach with metformin initiated in treatment naïve patients (n=2001) in a […]readmore